Skip to content
Norton & Elaine Sarnoff Center for Jewish Genetics Logo
  • Home
  • Get Screened
  • About Us
    • Board Members
    • Staff
  • Genetic Disorders
    • Types of Genetic Disorders
    • Jewish Genetic Disorder FAQs
    • Rabbinical Insights
  • Hereditary Cancer
    • BRCA Mutations
    • Lynch Syndrome
    • Assess Your Risk
    • Cancer FAQs
    • Cancer Resources
  • Resources
    • Preimplantation Genetic Testing
    • Family Health History
    • Teach Jewish Genetics
    • Community Resources
    • Educational Brochures
    • For Medical Professionals
    • Personal Stories
    • Blog
  • Get Involved
    • Events
    • Donate
Previous Next

FKTN-Related Disorders

FKTN-related disorders encompass a spectrum of conditions causing muscle weakness due to a deficiency in the fukutin protein.

The severity of symptoms varies widely, even within the same family. The disorders range from the most severe, Walker-Warburg Syndrome (WWS), characterized by significant muscle weakness, vision problems, brain structural changes, and severe intellectual disabilities. Impaired vision can result from various eye issues, and brain changes often lead to abnormal folding or fluid buildup. Children with WWS are typically unable to sit or walk independently and often experience seizures.

Fukuyama Congenital Muscular Dystrophy (FCMD) and Muscle-Eye-Brain Disease (MEB) share overlapping symptoms with WWS but tend to be less severe. Muscle weakness, brain structural alterations, and eye abnormalities are present, although some individuals with FCMD or MEB may learn to walk and speak a few words at later stages.

Limb Girdle Muscular Dystrophy Type 2M (LGMD2M) represents the mildest form of FKTN-related disorders, characterized by weakness in muscles near the body’s center, particularly in shoulders, upper arms, pelvic area, and thighs. Heart conditions like dilated cardiomyopathy are rare in this presentation, and the brain and eyes remain unaffected. Currently, there is no cure for these disorders. Treatment focuses on managing symptoms, which may involve seizure medications, brain fluid reduction surgery, feeding tube placement, and physical and occupational therapy for more severe cases. Management for LGMD2M mainly includes physical therapy, assistive devices, and monitoring for heart and breathing complications.

These conditions are caused by pathogenic (disease-causing) variants in the FKTN gene and exhibits autosomal recessive inheritance. This means that both parents must be carriers to have a 25% chance to have a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background. For example, individuals of Ashkenazi Jewish descent have a 1 in 80 chance to be a carrier. Carriers typically do not experience any symptoms. 

Other names for this condition include Walker-Warburg syndrome, limb girdle muscular dystrophy type 2M, Fukuyama congenital muscular dystrophy/muscle-eye-brain disease, and FKTN-related dystrophies. 

Resources:  

Limb Girdle Awareness Foundation

National Organization for Rare Disorders (NORD)

Revised October 2023

admin2023-10-12T17:11:57+00:00July 26, 2022|

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

About the Author: admin

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of the Jewish United Fund, and is supported in part by the Michael Reese Health Trust.

30 S Wells
Chicago, IL 60606
312-357-4718
jewishgenetics@juf.org

About
  • About Us
  • Genetic Disorders
  • Hereditary Cancer
  • Donate
Resources
  • Medical Professionals
  • Teach Jewish Genetics
  • Events

©2025 Norton & Elaine Sarnoff Center for Jewish Genetics

Page load link
Go to Top